|
|
 |
|
BAX: Baxter Intl Inc - Stock News |
Enter Ticker:
|
|
| Nov 16, 2009 |
Zacks Analyst Blog Highlights: GlaxoSmithKline plc, Sanofi-Aventis, Novartis, Baxter International and AstraZeneca |
| Nov 14, 2009 |
Glaxo H1N1 Vaccine Approved |
| Nov 14, 2009 |
Baxter Increases Quarterly Dividend |
| Nov 12, 2009 |
Baxter International (BAX) NewsBite - Economic Worries Pull Down BAX |
| Nov 12, 2009 |
Baxter Lauds CMS' Kidney Treatment Option Education Program |
| Nov 10, 2009 |
Daily Dividend Report: RSH, MMM, HAL, L, BAX |
| Nov 10, 2009 |
Baxter International Board Of Directors Declared Quarterly Dividend Of 29 Cents (BAX) |
| Nov 10, 2009 |
Baxter Raises Quarterly Dividend |
| Nov 09, 2009 |
New Medicare Benefit to Provide Chronic Kidney Disease Patients with Education on Treatment Options |
| Nov 07, 2009 |
Baxter to Make Presentation at the 2009 Annual Credit Suisse Health Care Conference |
| Nov 03, 2009 |
Baxter to Present at the 2009 Annual Credit Suisse Health Care Conference |
| Oct 25, 2009 |
Hospitals queue up for CSL lawsuit |
| Oct 25, 2009 |
Hospitals in queue to sue CSL |
| Oct 16, 2009 |
Baxter International (BAX) Bullish Technical Alert - Trend Up 7.5% |
| Oct 15, 2009 |
Baxter Earnings Up 12% |
| |
| ZACKS COMMENTARY FOR BAX |
| Nov 23, 2009 | Zacks Blog: Becton Acquires HandyLab | | Nov 16, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: GlaxoSmithKline plc, Sanofi-Aventis, Novartis, Baxter International and AstraZeneca | | Nov 13, 2009 | Zacks Blog: Glaxo H1N1 Vaccine Approved | | Nov 03, 2009 | Zacks Blog: Haemonetics Reports Strong Results | | Oct 27, 2009 | Zacks Blog: Becton Set for Acquisition | | Oct 23, 2009 | Zacks Equity Research: Report for BAX | | Oct 19, 2009 | Zacks Blog: Baxter Eyes Swine Flu Market | | Oct 15, 2009 | Zacks Blog: Medical Devices | | Oct 15, 2009 | Zacks Blog: Baxter Beats, Raises Outlook | | Oct 15, 2009 | Zacks Blog: Company News for October 15, 2009 | | Oct 12, 2009 | Zacks Blog: Becton Receives FDA Approval | | Oct 09, 2009 | Zacks Blog: Sanofi Vaccine Proves Beneficial |
|
|
Sponsored Links 
0.40